XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Impact of new accounting pronouncements
Impact of new accounting pronouncements
Retained Earnings
Beginning Balance at Dec. 31, 2019 $ 1,815,705 $ 7,175 $ 310,778 $ (816,803) $ 2,301,532 $ 13,023 $ (209) $ (209)
Beginning balance (in shares) at Dec. 31, 2019   100,198            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 80,236       80,445 (209)    
Other comprehensive income/(loss):                
Translation gain/(loss) (95,212)     (93,575)   (1,637)    
Defined benefit plan adjustment, net of tax 5,780     5,780        
Derivative financial instruments, net of tax (4,555)     (4,555)        
Other comprehensive income/(loss) (93,987)     (92,350)   (1,637)    
Dividends (43,339)       (43,339)      
Issuance of stock awards 376   376          
Issuance of stock awards (in shares)   196            
Shares repurchased (3,938)   (3,938)          
Shares repurchased (in shares)   (65)            
Stock-based compensation 597   597          
Ending Balance at Mar. 29, 2020 1,755,441 $ 7,175 307,813 (909,153) 2,338,429 11,177    
Ending balance (in shares) at Mar. 29, 2020   100,329            
Beginning Balance at Dec. 31, 2019 1,815,705 $ 7,175 310,778 (816,803) 2,301,532 13,023 $ (209) $ (209)
Beginning balance (in shares) at Dec. 31, 2019   100,198            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 218,524              
Other comprehensive income/(loss):                
Translation gain/(loss) (37,701)              
Defined benefit plan adjustment, net of tax 15,476              
Derivative financial instruments, net of tax (440)              
Other comprehensive income/(loss)       (20,411)        
Ending Balance at Sep. 27, 2020 1,881,333 $ 7,175 310,912 (837,214) 2,390,272 10,188    
Ending balance (in shares) at Sep. 27, 2020   100,416            
Beginning Balance at Mar. 29, 2020 1,755,441 $ 7,175 307,813 (909,153) 2,338,429 11,177    
Beginning balance (in shares) at Mar. 29, 2020   100,329            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 54,990       55,211 (221)    
Other comprehensive income/(loss):                
Translation gain/(loss) 32,864     33,454   (590)    
Defined benefit plan adjustment, net of tax 4,416     4,416        
Derivative financial instruments, net of tax 1,830     1,830        
Other comprehensive income/(loss) 39,110     39,700   (590)    
Dividends (43,451)       (43,451)      
Issuance of stock awards 287   287          
Issuance of stock awards (in shares)   2            
Shares repurchased (12)   (12)          
Shares repurchased (in shares)   (1)            
Stock-based compensation 1,339   1,339          
Ending Balance at Jun. 28, 2020 1,807,704 $ 7,175 309,427 (869,453) 2,350,189 10,366    
Ending balance (in shares) at Jun. 28, 2020   100,330            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 83,298       83,449 (151)    
Other comprehensive income/(loss):                
Translation gain/(loss) 24,647     24,674   (27)    
Defined benefit plan adjustment, net of tax 5,280     5,280   0    
Derivative financial instruments, net of tax 2,285     2,285   0    
Other comprehensive income/(loss) 32,212     32,239   (27)    
Dividends (43,366)       (43,366)      
Issuance of stock awards 256   256          
Issuance of stock awards (in shares)   150            
Shares repurchased (3,385)   (3,385)          
Shares repurchased (in shares)   (64)            
Stock-based compensation 4,614   4,614          
Ending Balance at Sep. 27, 2020 1,881,333 $ 7,175 310,912 (837,214) 2,390,272 10,188    
Ending balance (in shares) at Sep. 27, 2020   100,416            
Beginning Balance at Dec. 31, 2020 $ 1,910,528 [1] $ 7,175 314,056 (756,842) 2,335,216 10,923    
Beginning balance (in shares) at Dec. 31, 2020 100,447 100,447            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) $ 72,293       72,297 (4)    
Other comprehensive income/(loss):                
Translation gain/(loss) (32,541)     (32,021)   (520)    
Defined benefit plan adjustment, net of tax 5,385     5,385        
Derivative financial instruments, net of tax 958     958        
Other comprehensive income/(loss) (26,198)     (25,678)   (520)    
Dividends (45,510)       (45,510)      
Issuance of stock awards 364   364          
Issuance of stock awards (in shares)   245            
Shares repurchased (5,051)   (5,051)          
Shares repurchased (in shares)   (85)            
Stock-based compensation 6,372   6,372          
Ending Balance at Apr. 04, 2021 1,912,798 $ 7,175 315,741 (782,520) 2,362,003 10,399    
Ending balance (in shares) at Apr. 04, 2021   100,607            
Beginning Balance at Dec. 31, 2020 $ 1,910,528 [1] $ 7,175 314,056 (756,842) 2,335,216 10,923    
Beginning balance (in shares) at Dec. 31, 2020 100,447 100,447            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) $ (150,391)              
Other comprehensive income/(loss):                
Translation gain/(loss) (57,686)              
Defined benefit plan adjustment, net of tax 429,823              
Derivative financial instruments, net of tax 5,370              
Other comprehensive income/(loss)       377,932        
Ending Balance at Oct. 03, 2021 $ 1,860,732 $ 7,175 172,655 (378,910) 2,049,072 10,740    
Ending balance (in shares) at Oct. 03, 2021 98,326 98,326            
Beginning Balance at Apr. 04, 2021 $ 1,912,798 $ 7,175 315,741 (782,520) 2,362,003 10,399    
Beginning balance (in shares) at Apr. 04, 2021   100,607            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) (334,239)       (334,070) (169)    
Other comprehensive income/(loss):                
Translation gain/(loss) 12,596     11,837   759    
Defined benefit plan adjustment, net of tax 422,745     422,745        
Derivative financial instruments, net of tax 3,482     3,482        
Other comprehensive income/(loss) 438,823     438,064   759    
Dividends (45,503)       (45,503)      
Issuance of stock awards 246   246          
Issuance of stock awards (in shares)   41            
Shares repurchased (154,519)   (154,519)          
Shares repurchased (in shares)   (1,819)            
Stock-based compensation 4,827   4,827          
Ending Balance at Jul. 04, 2021 1,822,433 $ 7,175 166,295 (344,456) 1,982,430 10,989    
Ending balance (in shares) at Jul. 04, 2021   98,829            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 111,555       111,140 415    
Other comprehensive income/(loss):                
Translation gain/(loss) (37,741)     (37,077)   (664)    
Defined benefit plan adjustment, net of tax 1,693     1,693   0    
Derivative financial instruments, net of tax 930     930   0    
Other comprehensive income/(loss) (35,118)     (34,454)   (664)    
Dividends (44,498)       (44,498)      
Issuance of stock awards 251   251          
Issuance of stock awards (in shares)   3            
Shares repurchased (83)   (83)          
Shares repurchased (in shares)   (506)            
Stock-based compensation 6,192   6,192          
Ending Balance at Oct. 03, 2021 $ 1,860,732 $ 7,175 $ 172,655 $ (378,910) $ 2,049,072 $ 10,740    
Ending balance (in shares) at Oct. 03, 2021 98,326 98,326            
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.